论文信息 - Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B‐cell non‐Hodgkin lymphoma - 字舞流文

Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B‐cell non‐Hodgkin lymphoma

M. Taniwaki | S. Nawano | M. Ogura | K. Tobinai | T. Uchida | K. Ishizawa | K. Itoh | K. Ando | Y. Morishima | Takashi Watanabe | T. Hotta | T. Terauchi | M. Nakata | M. Matsusako | J. Yamamoto | M. Hayashi